Antiandrogen Therapy Radiosensitizes Androgen Receptor-Positive Cancers to (18)F-FDG. Singaravelu I, Spitz H, Mahoney M, Dong Z, et al. J Nucl Med 2022;63:1177-1183.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Singaravelu I, Spitz H, Mahoney M, Dong Z, et al. Antiandrogen Therapy Radiosensitizes Androgen Receptor-Positive Cancers to (18)F-FDG. J Nucl Med 2022;63:1177-1183.
PMID: 34772792